Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property space

Abstract

Extensive biochemical and clinical studies have increasingly recognized Parkinson's disease as a highly complex and multi-faceted neurological disorder having branched non-motor symptoms including sleep disorders, pain, constipation, psychosis, depression, and fatigue. A wide range of biological targets in the brain deeply implicated in this pathology resulted in a plethora of novel small-molecule compounds with promising activity. This review thoroughly describes the chemical space of non-dopamine receptor ligands in terms of diversity, isosteric/bioisosteric morphing, and molecular descriptors.

Keywords: Bioisosteres; Descriptors; Diversity; Drugs; Non-dopamine; Parkinson’s disease.